# Assessment of New Radiation Oncology Technologies and Treatments

> **NCT01379872** · — · COMPLETED · sponsor: **Trans Tasman Radiation Oncology Group** · enrollment: 138 (actual)

## Conditions studied

- Prostate Cancer (Post Prostatectomy)
- Anal Cancer
- Nasopharyngeal Cancer
- Intermediate Risk Prostate Cancer

## Interventions

- **OTHER:** Non-Interventional Study

## Key facts

- **NCT ID:** NCT01379872
- **Lead sponsor:** Trans Tasman Radiation Oncology Group
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2012-05
- **Final completion:** 2012-06
- **Target enrollment:** 138 (ACTUAL)
- **Last updated:** 2013-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01379872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01379872, "Assessment of New Radiation Oncology Technologies and Treatments". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01379872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*